We examined structure and expression of the p53 and Rb genes in a C3HOS transplantable mouse model of osteosarcoma. The results were compared to analogous studies conducted with five human osteosarcoma cell lines. The p53 gene was found rearranged in the mouse tumour. The rearrangement mapped to the first intron region of the p53 gene and as a result, no p53 expression could be detected in C3HOS tumours. Using p53 genomic probes, we have detected the same rearrangement in the original radiation-induced tumour and the various clones that were isolated from it. Deletion and rearrangement of the p53 gene were also found in three out of five of the human osteosarcoma cell lines . No p53 expression could be detected in these three cell lines. In the affected human osteosarcoma cell lines, the rearrangement involved the first intron region. In addition, the mouse tumour was analysed for structural and expression changes in the Rb and the c-myc genes. Normal expression of both genes were detected in the murine tumour. Only one (Saos-2) human osteosarcoma cell line exhibited gross structural alteration in the retinoblastoma gene. The results suggest that the inactivation of p53 may be an important step in the development of osteosarcomas, and that a rearrangement affecting the first intron is common in osteosarcomas.
Cytogenetic investigations of human osteosarcoma reveal a variety of chromosomal abnormalities, some of which are presumed to have a direct relationship to the disease (Gilman et al., 1985) . A frequent loss of heterozygosity has been localised on specific regions of chromosomes 17 (Toguchida et al., 1988) and 13 (Toguchida et al., 1989) . In both cases, the deleted chromosomal loci involve tumour suppressor genes, the retinoblastoma gene on chromosome 13 (Friend et al., 1987) and the p53 on chromosome 17 (Miller et al., 1986) .
The retinoblastoma gene (Rb) was first identified as a tumour suppressor gene, as it was found inactivated in both sporadic and familial retinoblastoma tumours (Friend et al., 1987; Lee et al., 1987; Hansen et al., 1985 . Subsequently the Rb gene was found to be inactivated in a number of other tumours (Lee et al., 1988; Harbour et al., 1988) , including osteosarcomas that arose either as primary or secondary tumours (Dryja et al., 1986; Reissmann et al., 1989) . The p53 gene was originally considered a dominant oncogene, but several lines of evidence have established that the wild-type gene product actually functions as a tumour suppressor (Finlay et al., 1989; Eliyahu et al., 1989) . Like the Rb gene, the p53 gene is implicated in the pathogenesis of various human malignancies through loss of function mutations Nigro et al., 1989) . It was previously reported that primary osteosarcoma lacks a functional p53 gene (Masuda et al., 1987; Miller et al., 1990) . Many of the animal models of osteosarcoma are poor representatives of the human disease. The cell lines derived from human, as well as animal osteosarcomas rarely produce tumours upon injection into immunodeficient or syngeneic animals. Thus, most of the information on tumour suppressor genes in osteosarcoma has been derived from surgical specimens of human osteosarcomas and established osteosarcoma cell lines.
Amplification and overexpression of some proto-oncogenes, such as c-raf, c-myc (Ikeda et al., 1989) , and c-fos (Wu et al., 1990) have been observed in some human osteosarcomas. Similarly, c-myc was amplified in 30% of radiationinduced murine osteosarcomas (Schon et al., 1986; Sturm et al., 1990 (Choi et al., 1979) . Early passages of the original tumour were inoculated s.c. into C3H/F/Sed mice (Department of Radiology, MGH) and converted into cell cultures. Subsequently, several clones (F6, BlO, G8, and C7) with differing growth and differentiation properties were isolated. The F6 and B10 clones were chosen for detailed characterisation as high and low differentiated variants, respectively. These were established as transplantation lines, maintained and passaged every 4-6 weeks in syngeneic mice. Tissue culture lines were also simultaneously maintained. MC3T3-El, an established murine osteoblast cell line (Kodama et al., 1981) , and liver tissue from a C3H mouse were used as controls for RNA and DNA analyses. (Chandar et al., 1987 For analysis of the human first exon we used plasmid pBT53 (Lamb & Crawford, 1986) . The p 4.7R human Rb cDNA (Friend et al., 1987) was cut to release the 3.8 and 0.6 kb segments to study the 3' and 5' regions of the gene, respectively. The murine Rb cDNA (pmRblO2) (Bernards et al., 1989) was employed for studies of the murine gene. The rat P-actin (pR PA-1) was obtained from the laboratory of Dr Lawrence Kedes and used as a control in RNA hybridisations. All inserts were labelled by random priming method (Feinberg & Vogelstein, 1983 Figure 2 . Other restriction enzymes were employed in efforts to produce fragments that cut within the p53 gene. The enzymes, HindlII and BamH 1, cut in the 6.1 kb first intron region as well as at other sites of the gene (Figure 2 ). Other enzymes, Sac-I, Kpn-I and Pst-I also cut within this region (Bienz et al., 1984) and were therefore employed. BamHl digestion gave 10.5 (pseudogene) and 6.0 kb bands in normal DNA. Part of the first intron and exons 2-6 of the p53 gene are contained within the 6.0 kb fragment. This fragment appeared as a 7.5 kb band in the tumours. Similar results were observed with HindlIl. Data obtained with other restriction enzymes are shown in Table I . Digestions of control and tumour DNA with Sac-I or Pst-I produced normal band patterns. In contrast, Kpn-I digestion of DNA from F6 and BlO tumours gave a 6.0 kb band in place of a 4.5 kb fragment obtained from control cells (Table I) (Bienz et al., 1984) . alteration, we utilised genomic DNA probes to determine the status of the non-coding first exon. The mouse probe specific for the first exon when hybridised to the ECoRI-digested DNA identified a novel 3.8 kb fragment, but did not bind to the larger 13 kb fragment (Figure 3) . In control tissue, this probe bound to the 16 kb fragment. In Kpn-I digests a 6.0 kb band was seen in place of a 5.2 kb band (Figure 3) . The same was true for the Sac-I digest. In normal tissue, Sac-I cuts at sites in intron-I and 5' to exon-I yielding a 3.7 kb fragment. In tumours, a fragment about 0.6 kb larger than normal was obtained (data not shown). The above data demonstrate that the rearrangement was contained within the first 3 kb of the p53 first intron. The appearance of a novel fragment within the ECoR1 digest, about 0.8 kb larger than the expected length, suggested the presence of a sequence integrated within the first intron region. Further characterisation of this region will be required to confirm the nature of this integrated sequence. The integrated DNA, however, did not seem to markedly alter the region in its immediate vicinity and, therefore, most other restriction sites appeared intact.
Northern analysis
The transcription of the p53 gene was analysed by means of Northern analysis of total RNA isolated from tumour and control cells. While a normal 2.0 kb transcript was present in osteoblast cells, no message could be detected in the tumours (Figure 4) . In order to improve sensitivity, the poly A mRNA was used in place of total RNA preparations. Five .tg of poly A mRNA was run on a gel and blotted, but no p53 message could be detected. All Northern blots were rehybridised to P-actin for control and quantitative purposes utilising a 2.2 kb P-actin message (Figure 4 ).
Structure ofp53 gene in human osteosarcomas
Five osteosarcoma cell lines that were available in our laboratory were screened for structural and expression characteristics of their p53 gene using ECORI and HindIII digests. As seen from the map (Figure 5) (Figure 6 ). The presence of a normal 4.7 kb transcript could be detected in the osteoblast cell line MC3T3-El, as well as in tumours.
A similar analysis was conducted with human osteosarcoma cell lines. The 3.8 and 0.6 kb Rb gene specific probes span a large region of the Rb gene and bind to several sequences on HindIII digests as depicted in Figure 7 . In HindIII digests, deletion of the 3' end of the Saos-2 gene was evident. U-20S showed decreased hybridisation to these probes, but no quantitative differences were found. The latter alterations were confirmed with ECORl digests (not shown). Hybridisation of the 0.6 kb probe to HindII digest showed that 14.0, 7.0, 6.0, 1.5, and 1.2 kb fragments were present in all the osteosarcoma cell lines tested. U-20S cells are likely to contain only one intact allele as judged by decreased hybridisation. In the Y79 retinoblastoma cell line, the 7.0 kb band was absent. Northern analysis was performed with the 3.8 kb probe and 4.7 kb transcripts could be detected in all cell lines, with the exception of the Saos-2 and Y79 cell lines (data not shown).
Analysis of c-myc in the murine tumour We also attempted to determine whether C3HOS contained tumour alterations in c-myc, as this has been a consistent observation in murine osteosarcoma tumours (Sturm et al., 1990) . Assays were conducted to uncover alterations in c-myc gene structure and expression. ECOR1 digests of normal and tumour DNA gave a 20 kb band for c-myc gene in all the samples analysed and expression of normal levels of a 2.2 kb RNA transcript was observed (data not shown). (Masuda et al., 1987; Miller et al., 1990) . Our data concerning p53 expression in G-292 are in agreement with observations by Diller et al. (1990) is present in the original radiation-induced tumour, as well as its clonal derivatives. The clones produce tumours with different growth rates and properties upon injection into animals. The rearrangement within the p53 gene has not changed over many generations both in vitro and in vivo. This indicates the importance of the described p53 aberration for the maintenance of the tumourigenic state. This is further supported by a recent study of primary osteosarcomas where 18% of the tumours that had rearranged p53 genes, had the alteration mapping to the first intron region (Miller et al., 1990) . The inactivation of p53 via alteration within the first intron thus appears to be unique to osteosarcoma and different from other human cancers where p53 inactivation occurs primarily by a loss of alleles and/or point mutations. This does not, however, preclude the occurrence of other mutations. In fact, in a recent study of sarcomas, gross alterations in p53 with lack of expression, or aberrant expression of p53 were detected at high frequency in osteosarcoma and rhabdomyosarcoma (Mulligan et al., 1990) . Irrespective of the mechanism, the alteration of normal p53 function has an important role in neoplasia. Gross rearrangements of p53 have been reported in virusinfected erythroleukaemia cells (Mowat et al., 1985; Munroe et al., 1990) , as well as in Ab-MuLv transformed lymphoid cells (Wolf & Rotter, 1984) . In the latter case, the inactivation of the gene is a result of an insertion of the Mo-MuLVlike DNA sequences into the first intron of the active gene in these cells (Wolf & Rotter, 1984) . These modifications appear analogous to those seen in osteosarcomas and may reflect a common pathway for tumour initiation from multipotent precursor cells. Alternately, its similarity to virus-induced alterations suggest that activation of endogenous retroviruses that frequently occur in radiation-induced tumours may have a role in the induction of the murine tumour (Schmidt et al., 1988) .
Amplification of the c-myc gene has been reported in 30% of the murine osteosarcomas tested (Strum et al., 1990 ). We did not see amplification of c-myc in the C3HOS tumour or the human osteosarcoma cell lines. The absence of the oncogene amplification phenomenon could be due to the fact that this change is a progression-related event, not directly involving the carcinogenic process.
Our studies showed that structural rearrangements of Rb antioncogenes may not be prevalent in human osteosarcoma, since only one out of five cell lines showed gross alteration of the Rb gene. The Rb gene in the mouse tumour also appears intact and synthesises a normal 4.7 kb transcript. However, given the large size of the gene and the wide variety of ways that the Rb gene can be inactivated (Cavenee, 1991) , our data cannot exclude the involvement of Rb in neoplastic transformation of cells under study. Nevertheless, the analyses of Rb protein have been carried out in the same osteosarcoma cell lines we examined and have appeared normal (Shew et al., 1989) .
A large amount of data have been accumulated concerning the various p53 mutations in human cancers Hollstein et al., 1991) . Functionally, p53 appears similar to the retinoblastoma gene . It, therefore, seems reasonable to suggest that the tumourigenic process may require inactivation of either one of the genes.
Alternatively, if p53 and Rb antioncogenes form a part of the cellular interactive regulatory mechanism, inactivation of one may, in effect, lead to inactivation of the other. Intron functions of several genes in transgenic mice have been tested (Brinster et al., 1988) , and were found to increase the transcriptional efficiency of genes introduced into mice. This observation has also been extended to include the p53 gene (Lozano et al., 1991) . Studies are in progress to determine the nature of alteration in the first intron of the human and murine osteosarcoma p53 genes. 
